156 related articles for article (PubMed ID: 35116712)
21. CCHE1 accelerated the initiation of oral squamous cell carcinoma through enhancing PAK2 expression by sponging miR-922.
Wang Y; Tong J; Lin H; Ma L; Xu Y
J Oral Pathol Med; 2020 Aug; 49(7):636-644. PubMed ID: 31981240
[TBL] [Abstract][Full Text] [Related]
22. LINC00958/miR-627 signal axis regulates the proliferation, migration, and invasion of thyroid papillary carcinoma cells by TRIM44.
Li YQ; Wang LC; Li AX; Huang W; Song Y; Wang W
Kaohsiung J Med Sci; 2022 May; 38(5):415-424. PubMed ID: 35199939
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNA.
Yang M; Zhai X; Xia B; Wang Y; Lou G
Tumour Biol; 2015 Sep; 36(10):7615-22. PubMed ID: 25921283
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells.
Cui M; Chang Y; Du W; Liu S; Qi J; Luo R; Luo S
Med Sci Monit; 2018 Jul; 24():5152-5158. PubMed ID: 30042377
[TBL] [Abstract][Full Text] [Related]
25. Novel LncRNA AK023507 inhibits cell metastasis and proliferation in Papillary Thyroid Cancer through β-catenin/Wnt Signaling Pathway.
Yang M; Huang S; Zhao Y; Xie B; Hu X; Cai Y
Biochem Biophys Res Commun; 2023 May; 655():104-109. PubMed ID: 36934585
[TBL] [Abstract][Full Text] [Related]
26. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.
Liao T; Qu N; Shi RL; Guo K; Ma B; Cao YM; Xiang J; Lu ZW; Zhu YX; Li DS; Ji QH
Oncotarget; 2017 Jan; 8(1):238-247. PubMed ID: 27462868
[TBL] [Abstract][Full Text] [Related]
27. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
[TBL] [Abstract][Full Text] [Related]
28. Silencing of Long Non-coding RNA ENST00000606790.1 Inhibits the Malignant Behaviors of Papillary Thyroid Carcinoma through the PI3K/AKT Pathway.
Zuo Z; Liu L; Song B; Tan J; Ding D; Lu Y
Endocr Res; 2021 Feb; 46(1):1-9. PubMed ID: 32791924
[TBL] [Abstract][Full Text] [Related]
29. CircRNA NRIP1 promotes papillary thyroid carcinoma progression by sponging mir-195-5p and modulating the P38 MAPK and JAK/STAT pathways.
Li C; Zhu L; Fu L; Han M; Li Y; Meng Z; Qiu X
Diagn Pathol; 2021 Oct; 16(1):93. PubMed ID: 34689819
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA DUXAP8 promotes the cell proliferation, migration, and invasion of papillary thyroid carcinoma via miR-223-3p mediated regulation of CXCR4.
Liu Y; Zhang H; Wang H; Du J; Dong P; Liu M; Lin Y
Bioengineered; 2021 Dec; 12(1):496-506. PubMed ID: 33522355
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA LINC00520 accelerates progression of papillary thyroid carcinoma by serving as a competing endogenous RNA of microRNA-577 to increase Sphk2 expression.
Sun Y; Shi T; Ma Y; Qin H; Li K
Cell Cycle; 2020 Apr; 19(7):787-800. PubMed ID: 32075502
[TBL] [Abstract][Full Text] [Related]
32. UCA1 promotes papillary thyroid carcinoma development by stimulating cell proliferation via Wnt pathway.
Lu HW; Liu XD
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5576-5582. PubMed ID: 30229831
[TBL] [Abstract][Full Text] [Related]
33. Expression and clinical diagnostic value of CCHE1 in breast cancer.
Zhao F; Zhou W; Xin R; Miao X
Mutagenesis; 2024 Mar; 39(2):141-145. PubMed ID: 38150355
[TBL] [Abstract][Full Text] [Related]
34. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
Meng XF; Zhao LY; Chu XF
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
[TBL] [Abstract][Full Text] [Related]
35. Circ_0079558 promotes papillary thyroid cancer progression by binding to miR-26b-5p to activate MET/AKT signaling.
Zheng H; Fu Q; Ma K; Shi S; Fu Y
Endocr J; 2021 Nov; 68(11):1247-1266. PubMed ID: 34565758
[TBL] [Abstract][Full Text] [Related]
36. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
Pang R; Yang S
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor.
Feng K; Liu Y; Xu LJ; Zhao LF; Jia CW; Xu MY
Biomed Pharmacother; 2018 Aug; 104():686-698. PubMed ID: 29803929
[TBL] [Abstract][Full Text] [Related]
38. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA BCAR4 accelerates cell proliferation and suppresses cell apoptosis in gastric cancer via regulating MAPK/ERK signaling.
Zhou GR; Huang DP; Sun ZF; Zhang XF
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3657-3664. PubMed ID: 32329841
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of ANXA10 inhibits proliferation and promotes apoptosis of papillary thyroid carcinoma cells by down-regulating TSG101 thereby inactivating the MAPK/ERK signaling pathway.
Wei T; Zhu X
J Bioenerg Biomembr; 2021 Aug; 53(4):429-440. PubMed ID: 34032966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]